Gärtner, Jutta – MBExC https://mbexc.de/de/ Multiscale Bioimaging - Cluster of Excellence Tue, 06 Jan 2026 14:23:02 +0000 de hourly 1 https://mbexc.de/storage/2020/01/X-icon.png Gärtner, Jutta – MBExC https://mbexc.de/de/ 32 32 Unlocking microglia pyroptosis in a model of type I interferon-driven neuroinflammation: lessons from Rnaset2-/- mice. https://mbexc.de/de/unlocking-microglia-pyroptosis-in-a-model-of-type-i-interferon-driven-neuroinflammation-lessons-from-rnaset2-mice/ Sat, 27 Dec 2025 14:18:22 +0000 https://mbexc.de/?p=24940 Microglia-neuron crosstalk via Hex-GM2-MGL2 maintains brain homeostasis https://mbexc.de/de/microglia-neuron-crosstalk-via-hex-gm2-mgl2-maintains-brain-homeostasis/ Wed, 06 Aug 2025 12:17:45 +0000 https://mbexc.de/?p=24050 Super-resolution microscopy of mitochondrial mRNAs https://mbexc.de/de/super-resolution-microscopy-of-mitochondrial-mrnas/ Thu, 10 Jul 2025 15:23:41 +0000 https://mbexc.de/?p=21168 The inner nuclear layer in pediatric multiple sclerosis https://mbexc.de/de/the-inner-nuclear-layer-in-pediatric-multiple-sclerosis/ Wed, 26 Mar 2025 12:45:31 +0000 https://mbexc.de/?p=21777 Folate receptor α deficiency – Myelin-sensitive MRI as a reliable biomarker to monitor the efficacy and long-term outcome of a new therapeutic approach https://mbexc.de/de/folate-receptor-%ce%b1-deficiency-myelin-sensitive-mri-as-a-reliable-biomarker-to-monitor-the-efficacy-and-long-term-outcome-of-a-new-therapeutic-approach-2/ Wed, 10 Jan 2024 08:06:02 +0000 https://mbexc.de/?p=19063 Tazarotene and Bexarotene Show Efficacy as In Vitro Therapeutic Agents in Multiple Sulfatase Deficiency https://mbexc.de/de/tazarotene-and-bexarotene-show-efficacy-as-in-vitro-therapeutic-agents-in-multiple-sulfatase-deficiency/ Mon, 13 Nov 2023 08:53:17 +0000 https://mbexc.de/?p=17134 Evaluation of Novel Enhancer Compounds in Gentamicin-Mediated Readthrough of Nonsense Mutations in Rett Syndrome https://mbexc.de/de/evaluation-of-novel-enhancer-compounds-in-gentamicin-mediated-readthrough-of-nonsense-mutations-in-rett-syndrome/ Wed, 19 Jul 2023 08:53:55 +0000 https://mbexc.de/?p=22668 Drug screening identifies tazarotene and bexarotene as therapeutic agents in multiple sulfatase deficiency https://mbexc.de/de/drug-screening-identifies-tazarotene-and-bexarotene-as-therapeutic-agents-in-multiple-sulfatase-deficiency/ Wed, 15 Feb 2023 10:35:13 +0000 https://mbexc.de/drug-screening-identifies-tazarotene-and-bexarotene-as-therapeutic-agents-in-multiple-sulfatase-deficiency/ Cln5 represents a new type of cysteine-based S-depalmitoylase linked to neurodegeneration https://mbexc.de/de/cln5-represents-a-new-type-of-cysteine-based-s-depalmitoylase-linked-to-neurodegeneration/ Fri, 15 Apr 2022 10:04:00 +0000 https://mbexc.de/?p=11498 Interferon-driven brain phenotype in a mouse model of RNaseT2 deficient leukoencephalopathy https://mbexc.de/de/interferon-driven-brain-phenotype-in-a-mouse-model-of-rnaset2-deficient-leukoencephalopathy/ Thu, 11 Nov 2021 11:54:34 +0000 https://mbexc.de/?p=9589